Table of Contents
This report analyzes the global market for Acute Coronary Syndrome Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 60 companies including Abbott Laboratories Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKli...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Louis
+1 718 618 4302
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use ...
Product Synopsis Disease-related, demographic, and desire-led drivers are making health of growing importance to food marketers. However, barriers such as cost, habits, and confusion over how to eat healthily ...
REPORT HIGHLIGHTS The global digital pathology market totaled nearly $2.1 billion in 2012. This market is expected to grow at a compound annual growth rate (CAGR) of 14.7% from $2.2 billion in 2013 to ...
... liver biopsy (currently only definitive test to confirm nash diagnosis and stage disease) simple steatosis nash liver prognosis good treat cardiac risks treat associated conditions pcps ...
... New congenital heart disease review what matters a commitment to research ensures that services are continually focussed on improvement and development, so networks will be required to have ...
... Claimed for critical illnesses and attacks without chest pain are a real occurrence stroke - friends life have removed the exclusion for a stroke due to traumatic injury to brain tissue or blood vessels ...
Reportlinker.com © Copyright 2014. All rights reserved.